|Articles|March 9, 2020
A New Approach to Benefiting the Endocannabinoid System
Author(s)Gencor
Endocannabinoids are neurotransmitters produced within the Endocannabinoid System. And cannabis, mainly CBD has emerged as a promising therapy. However, with all its legalities and quality concerns, many companies are looking for alternatives that similarly influence the endocannabinoid pathways.
Related Content
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
A New Frontier in Eye Health: Digital Wellness, Bioavailability, and the Eye-Brain Connection
2
Clasado Biosciences Partners with Prokopton SAS to Expand Bimuno GOS Distribution in France
3
Finished Product Clinical Validation Emerges as a Competitive Differentiator in the Supplement Industry
4
Lion’s Mane Ingredient Targets Standardized Erinacine A
5